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Fullerene (C60) derivatives, a unique class of compounds with potent antioxidant properties, have been reported
to exert a wide variety of biological activities including neuroprotective properties. Mitochondrial dynamics are
an important constituent of cellular quality control and function, and an imbalance of the dynamics eventually
leads to mitochondria disruption and cell dysfunctions. This study aimed to assess the effects of carboxylic acid
C60 derivatives (C60–COOH) on mitochondrial dynamics and elucidate its associated mechanisms in lipopolysaccharide
(LPS)-stimulated BV-2 microglial cell model. Using a cell-based functional screening system labeled with DsRed2-mito in
BV-2 cells, we showed that LPS stimulation led to excessive mitochondrial fission, increased mitochondrial localization of
dynamin-related protein 1 (Drp1), both of which were markedly suppressed by C60–COOH pretreatment. LPS-induced
mitochondria reactive oxygen species (ROS) generation and collapse of mitochondrial membrane potential (ΔΨm) were
also significantly inhibited by C60–COOH. Moreover, we also found that C60–COOH pretreatment resulted in the
attenuation of LPS-mediated activation of nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK)
signaling, as well as the production of pro-inflammatory mediators. Taken together, these findings demonstrated
that carboxylic acid C60 derivatives may exert neuroprotective effects through regulating mitochondrial dynamics
and functions in microglial cells, thus providing novel insights into the mechanisms of the neuroprotective properties
of carboxylic acid C60 derivatives.
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Mitochondria are organized in a highly dynamic tubular
network that is continuously shaped by complementary
fission and fusion events [1]. Mitochondria dynamics
regulate processes associated with mitochondria morph-
ology such as mitochondria biogenesis, localization, and
distribution as well as the morphology itself [2]. Defects
in either fission or fusion limit mitochondrial motility,
decrease energy production, and promote oxidative
stress, thereby resulting in cell dysfunction and death
[3]. Mitochondrial fission and fusion processes are regu-
lated by evolutionarily conserved molecular machinery.* Correspondence: yeshefang@xmu.edu.cn; ypy211@163.com
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provided the original work is properly creditedIn mammalian cells, a core machinery of mitochondria-
shaping proteins exists that impinges on the fusion-
fission equilibrium. It has been reported that the large
GTPase proteins, including outer membrane mitofusins
(Mfn-1 and Mfn-2) and inner membrane optic atrophy 1
(Opa1), assist in the mitochondrial fusion process in
mammalian cells [4]. Another class of GTPase proteins
including dynamin-related protein 1 (Drp1) promote
mitochondrial fission by interacting with its adaptor in
the outer membrane such as fission protein 1 (Fis1) and
mitochondrial fission factor [5]. Imbalanced mitochon-
drial dynamics are directly linked to many human dis-
eases including neurodegenerative diseases, metabolic
disorders, and cancer [6]. Despite accumulating data
currently available regarding the machinery of mito-
chondrial fission and fusion, the precise molecular
mechanisms are still not fully understood. Identification
of regulator of mitochondria dynamics should lead todistributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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ing mitochondria-associated diseases [4–6].
Fullerene C60, also called as buckminsterfullerenes or
buckyballs, is a unique spherical carbon molecule [7].
Due to its highly unsaturated structure and excellent
electron-receptor properties, C60 has been extensively
investigated as a radical scavenger [8]. This property
makes them attractive therapeutic options for the treat-
ment of oxidative stress-related chronic disorders. How-
ever, the extreme hydrophobicity and potential toxicity
of fullerene limit its application as a therapeutic agent.
Derivatization of water-soluble fullerenes by directly
adding hydrophilic group (eg., coupling with –COOH,
−OH, or –NH2) moieties to the carbon cage has been
used as a strategy to produce useful drug candidates [9],
and the evidence clearly demonstrated that with increas-
ing hydrophilicity, their toxicity decreased [7, 8]. Such
C60 derivatives including polyhydroxylated C60 (fullere-
nol) [10, 11], carboxylated fullerenes [10], and polysulfo-
nated C60 [12] have been shown to be useful for a wide
range of biomedical applications, including drug and gene
delivery [13], DNA photocleaving [7], extinction of react-
ive oxygen species (ROS) [10, 11, 14], anti-apoptosis [15,
16], antiviral activity [17], photodynamic therapy [7, 10],
neuroprotection [18–20], anti-inflammation [21], and
modulation of learning and memory [22]. Recently, the
anti-allergic [23], tumor-inhibitory, and immunomodula-
tory properties [24, 25] of fullerene derivatives have also
been described.
Microglia, the resident immune cells of the central
nervous system (CNS), participate in both innate and
adaptive immune responses [26]. However, overacti-
vated microglia cells are able to exert detrimental
neurotoxic effects through the excessive production of
various toxic factors, such as chemokines, eicosanoids,
cytokines, and reactive free radicals [27]. Although
these factors are necessary for immune surveillance of
the local brain environment, microglial responses must
be properly and tightly regulated so as to avoid overac-
tivation and associated disastrous neurotoxic conse-
quences. Thus, inhibition of microglial activation and
subsequent inflammatory process may provide thera-
peutic benefits for neurodegenerative disorders [28].
Regarding their various biological and pharmacological
properties, water-soluble carboxylic acid C60 derivatives
have been extensively investigated in the prevention of
neurodegenerative diseases, though molecular details
are still largely lacking. In this study, we sought to
examine the effects of carboxylic acid C60 derivatives
(C60–COOH) on the neuroninflammatory response in
lipopolysaccharide (LPS)-stimulated microglial BV-2
cell model, and elucidate whether modulation of mito-
chondrial dynamics are related to C60–COOH-medi-
ated attenuation of inflammatory responses.Methods
Preparation of Carboxylic Acid C60 Derivative
A water-soluble carboxylic acid C60 derivative was
prepared according to a previously reported method [29].
In brief, NaH was added to the solution of C60 (99.5 %
pure; Sigma, St. Louis, MO) in toluene. After the solution
changed to a dark-red color, diethyl bromomalonate
(Sigma, St Louis, MO, USA) was added. Under the protec-
tion of argon, the solution was stirred at 25 °C for 10 h.
After removal of the liquid phase, the residue was eluted
by toluene followed by addition of excess NaH. The solu-
tion was stirred under argon atmosphere at 80 °C for 10 h,
and the reaction was terminated by addition of methanol
containing HCl. The precipitate was then collected by
centrifugation, washed thoroughly with methanol, HCl,
and deionized water, and then subjected to silica gel col-
umn chromatography. MALDI-TOF mass spectrometry
(Shimadzu Biotech, Kyoto, Japan) verified the targeting
product (m/z = 1107). The Fourier transform infrared
spectroscopy (FTIR; iN10 MX IR, Nicolet) spectra exhibits
main peaks at 3439, 1718, 1201, and 523 cm−1, confirming
that C60 have been successfully modified by –COOH
(Fig. 1a). The molecular formula of carboxylic acid C60 de-
rivative was established as C60(C(COOH)2)3 (C60–COOH
for short). Dynamic light scattering (DLS) data using a
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK)
showed that the C60–COOH (50 μM) in culture medium
(10 % fetal bovine serum) appeared homogeneous with
the average size 82.5 nm (Fig. 1b). The C60–COOH sus-
pension were shown to be negative for endotoxins using
the limulus amebocyte lysate test (Pyrogent 5000®; Lonza,
Walkersville, MD).
Cell Culture and DNA Transfection
The murine BV-2 microglial cell lines (Cell Bank of
Chinese Academy of Sciences, Shanghai, China) were
grown in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco, GrandIsland, NY, USA) supplemented with 10 %
heat-inactivated fetal bovine serum (FBS; Life Technologies,
Carlsbad, CA, USA), streptomycin (10 μg/mL), and penicil-
lin (10 U/ml) (Invitrogen, Carlsbad, CA), and maintained at
37 °C in a humidified 5 % CO2 incubator. The cells were
grown to a density of 2 × 105 in a six-well plate for 24 h at
37 °C prior to initiating the experiments.
The DsRed2-mito gene, which contains DNA sequences
coding for DsRed2 fused at the 3′ end of the mitochon-
drial targeting sequence from subunit VIII of cytochrome
c oxidase, was derived from the plasmid pDsRed2-Mito
(Clontech, Palo Alto, CA, USA). The DsRed2-mito coding
sequence was amplified by PCR using LA Taq polymerase
(Takara, Shiga, Japan), and sequentially cloned into a lenti-
viral vector pLenti6/V5-DEST (Invitrogen, Carlsbad, CA,
USA), which contains a c-terminal V5 epitope tag that can
be fused to a gene of interest to allow protein detection by
Fig. 1 a FTIR spectrum of (a) raw C60; (b) C60(C(COOH)2)3. b The size distribution of C60(C(COOH)2)3 in culture medium (10 % fetal bovine serum)
obtained by dynamic light scattering (DLS). The concentration of C60(C(COOH)2)3 was 50 μM
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tiviral vectors at multiplicity of infection (MOI) of 5:1
were treated with 8 μg/mL polybrene (Sigma, St Louis,
MO, USA). The cells were then cultured for 72 h and the
DsRed2-mito expressing BV-2 cells were then selected for
resistance to 4 μg/mL blasticidin (Invitrogen, Carlsbad,
CA, USA). The resulting cell colonies were used for sub-
sequent proliferation and storage.
Cell Viability Assay
Cell viability was determined using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St
Louis, MO, USA) assay as previously described [11].
Briefly, BV-2 cells were grown on 96-well plates at a dens-
ity of 5 × 104 for 24 h. After treatment with C60–COOH at
various doses (10–100 μM) for 24 h, the cells were incu-
bated with MTT solution (0.5 mg/mL, 1 × PBS) for 2 h at
37 °C. The formazan crystals resulting from mitochondrial
enzymatic activity on MTT substrate were solubilized with
200 μL of dimethyl sulfoxide, and absorbance at 570 nm
was measured using a microplate reader (Model 680, Bio-
Rad Laboratories, Hercules, CA, USA). The results are
given relative to the untreated control.
Analysis of Mitochondrial Morphology
BV-2 cells expressing DsRed2-mito were seeded on poly-
D-lysine coated glass. The cells were treated with 1 μg/mL
LPS (Sigma, St. Louis, MO) for 12 h with or without
50 μM C60–COOH pretreatment for 6 h. Cells were fixed
with 4 % paraformaldehyde for 15 min and then incubated
with 0.5 μM MitoTracker green (Invitrogen, Carlsbad,
CA, USA) at 37 °C for 15 min. Images of the cells were ac-
quired using an LSM-710 confocal microscope (Carl Zeiss,Oberkochen, Germany). Mitochondrial length was mea-
sured with ImageJ software (NIH, Bethesda, MD, USA).
Analysis of mitochondrial morphology was performed by
counting more than 50 mitochondrial particles per cell in
over 20 cells according to a method previously described
[30]. Mitochondria were divided into different categories
based on length ranging from less than 1 μm, 1–3 μm,
and greater than 3 μm.
Measurement of Mitochondrial ROS Production
BV-2 cells were seeded at a density of 5 × 104 cells in
each well of 96-well plates and allowed to attach over
night, and then incubated with 1 μg/mL LPS for 6 h
with or without 50 μM C60–COOH pretreatment for
6 h. To examine accumulation of mitochondrial super-
oxide, trypsinized BV-2 cells were incubated with
2.5 μM MitoSOX Red mitochondrial superoxide indica-
tor (Invitrogen, Carlsbad, CA) 37 °C for 30 min, washed
twice with phosphate-buffered saline (PBS), and centri-
fuged at 800 g for 5 min. Cell pellets were re-suspended
in ice-cold PBS and quantification of MitoSOX Red
fluorescence was analyzed using a FACScan flow cytom-
etry (BD Biosciences) with excitation and emission wave-
lengths at 510/580 nm.
Mitochondrial Membrane Potential (ΔΨm) Assay
The lipophilic cationic probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzinidazolylcarbocyanine iodide (JC-1) dye
(Molecular Probes, Eugene, OR) was used to measure
mitochondrial inner membrane potential (ΔΨm) accord-
ing to the manufacturer’s instructions. JC-1 accumulates
in the mitochondria in proportion to ΔΨm and forms ag-
gregates emitting red fluorescence. In the cytoplasm, JC-1
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after incubation with 1 μg/mL LPS for 6 h in the absence
or presence of 50 μM C60–COOH pretreatment for 6 h,
cells were trypsinized and incubated with 5 μg/mL JC-1
for 30 min at room temperature in the dark. Then, the
cells were washed twice with PBS and visualized under a
fluorescence microscope (Eclipse TE300, Nikon, Japan).
Immunofluorescence Staining
BV-2 cells were fixed with 4 % paraformaldehyde at
room temperature for 20 min, permeabilized with 0.5 %
Triton X-100 in PBS, and then incubated with blocking
buffer (PBS, 5 % goat serum, and 0.3 % Triton X-100)
for 30 min. The cells were then labeled with primary
antibodies in blocking buffer at 4 °C overnight,
followed by incubation with secondary antibody. There-
after, cells were nuclear-stained via 15-min incubation
in a blocking solution containing 0.25 mg/mL DAPI
(Santa Cruz, CA, USA). Fluorescent-labeled cells were
imaged with LSM-710 confocal microscope (Carl Zeiss,
Oberkochen, Germany).
Protein Extract
Harvested BV-2 cells were washed twice with ice-cold
PBS. Then, the cells were lysed on ice in lysis buffer
consisting of 50 mM Tris–HCl (pH 8.0), 150 mM NaCl,
0. % sodium dodecyl sulfate (SDS), 1 % Triton X-100,
0.5 % sodium deoxycholate, 1 mM EDTA (Sigma, St.
Louis, MO, USA), 1 % protease inhibitor cocktail, and
1 % phosphatase inhibitor cocktail (Roche Diagnostics
Co., Indianapolis, IN). Nuclear and cytoplasmic frac-
tions were isolated using an NE-PER nuclear and
cytoplasmic extraction reagent kit (Thermo Scientific,
Waltham, MA, USA). Mitochondrial fractions were
prepared with a mitochondria isolation kit according to
the manufacturer’s protocol (Thermo Scientific, Waltham,
MA, USA). The protein concentration was determined
using the protein assay reagent (Bio-Rad Laboratories,
Hercules, CA).
Western Blot Analysis
Equal amounts of whole cell protein as well as nuclear,
mitochondrial, and cytoplasmic lysates were separated by
electrophoresis in 8–12 % sodium dodecyl sulfate poly-
acrylamide (SDS-PAGE) gels and transferred onto nitro-
cellulose membranes (Millipore, Bedford, MA, USA).
Primary antibodies used for immunoblotting included
anti-Drp1, anti-phosphorylated(p)-Drp1(Ser637), anti-
COX IV, anti-ERK, anti-p-ERK, anti-JNK, anti-p-JNK,
anti-p38, anti-p-p38 (Santa Cruz, CA, USA), anti-
iNOS, anti-COX-2, anti-β-actin, anti-Mfn1, anti-Mfn2,
anti-Fis1 (Sigma, St Louis, MO, USA), anti-Opa1 (BD
Biosciences), anti-V5, anti-NF-κB p65, and anti-lamin B
(Abcam, Cambridge, MA, USA). Membranes wereincubated overnight at 4 °C with primary antibodies
and then with their corresponding horseradish
peroxidase-conjugated secondary antibodies for 1 h at
room temperature. The immunoblots were detected
with enhanced chemiluminescence (ECL) reagents
(Amersham Biosciences, Piscataway, NJ, USA). Densi-
tometry data analysis was performed using ImageJ
software (NIH, Bethesda, MD, USA) and expressed in
arbitrary units.
Measurement of Inflammatory Mediators
BV-2 cells were pretreated with 50 μM C60–COOH for
6 h and then stimulated with 1 μg/mL LPS for 12 h.
Subsequently, prostaglandin E2 (PGE2), tumor necrosis
factors-α (TNF-α), interleukin-1β (IL-1β), and IL-6 levels
were quantified in the culture supernatants using enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems,
Minneapolis, MN), and nitric oxide (NO) production was
assayed using the Griess reagent assay (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
instructions.
Statistical Analysis
Results are presented as the means ± standard deviation
of the triplicate experiments. Comparisons between
groups were evaluated by two-sided Student’s t test or
one-way analysis of variance. A p value of less than 0.05
was considered statistically significant.
Results and Discussion
The Effects of C60–COOH on LPS-Induced Mitochondrial
Fission
To observe mitochondrial morphological changes, BV-2
cells were transiently transfected with a lentiviral vector
encoding mitochondria-targeting DsRed2 (DsRed2-mito)
[31]. Confocal laser microscopy confirmed that the ex-
pression of DsRed2-mito gene exhibited a characteristic
punctuate pattern of staining (Fig. 2a). To verify this find-
ing, the cells were co-stained with mitochondrial-specific
staining dyes Mitotracker green. Superimposition of the
two images revealed a considerable degree of overlap
between endogenous DsRed2-mito staining and the mito-
chondrial staining (Fig. 2a). Western blotting analysis of
mitochondrial and cytosolic fractions confirmed that the
expression of DsRed2-mito protein was only observed in
the mitochondrial fraction in BV-2 cells with a V5 anti-
body (Fig. 2b).
In healthy cells, mitochondrial fusion and fission is a
dynamic process critical for the maintenance of mito-
chondrial function and cell viability [2]. The change in
fission/fusion balance impacts mitochondrial function,
and LPS has been shown to affect this dynamics by
upregulating the fission protein dynamin-related pro-
tein 1 (Drp1), which results in disrupted distribution
Fig. 2 a BV-2 cells expressing the DsRed2-mito were observed
with a laser confocal microscopy after staining with MitoTracker
green. b Cytoplasm and mitochondrial fractions of wild-type and
DsRed2-mito BV-2 cells were analyzed by western blotting with
antibodies against theV5-epitope. Cytochrome c oxidase subunit
IV (COX IV) and β-actin were used as a mitochondria and cytoplasm
marker, respectively
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termine the optimal concentration of C60–COOH for
following analysis, we initially screen the sensitivity of
BV-2 cells to C60–COOH. Previous reports indicated
that carbon-based nanomatetials such as single-walled
carbon nanotubes (SWCNTs) might interfere when
tested with MTT [33]. However, MTT is a widely ac-
cepted test method for in vitro toxic study of C60 deriv-
atives [19, 34]. Results obtained from MTT assays
showed that C60–COOH up to 100 μM for 24 h was
well tolerated by BV-2 cells without any influence on
cell viability (Fig. 3a). For comparison to previous work
on C60–COOH in vitro studies [14, 16], a dose of
50 μM C60–COOH was used in the subsequent experi-
ments. To examine the effects of C60–COOH on
mitochondrial morphological changes, we established a
cell-based functional screening system using BV-2 cells
that stably expressed the DsRed2-mito gene. DsRed2-
mito expressing BV-2 cells were treated with 1 μg/mL
LPS in the absence or presence of 50 μM C60–COOH
pretreatment for 12 h, and the mitochondrial network
was visualized by confocal laser microscopy. As shown
in Fig. 3b, characteristics of mitochondrial fragmenta-
tions such as punctate and shorter mitochondria in
LPS-stimulated DsRed2-mito BV-2 cells were clearly
visible after 12 h compared to the untreated cells, inagreement with earlier reports [32]. However, C60–COOH
pretreatment significantly inhibited mitochondrial frag-
mentations induced by LPS in BV-2 cells (p < 0.05)
(Fig. 3c).
C60–COOH Inhibited LPS-Induced Translocation of Drp1 to
the Mitochondria
BV-2 cells pretreated with C60–COOH exhibited less
mitochondrial fragmentation compared with LPS-
stimulated cells, which suggested that C60–COOH
represent a novel inhibitor of mitochondrial fragmenta-
tion. Next, we measured the levels of mitochondrial fis-
sion and fusion proteins as evidence of mitochondrial
fragmentation. It has been reported that mitochondrial
fission requires translocation of Drp1 from the cytosol
to mitochondria. In addition, translocation of Drp1 to
mitochondria is controlled by Serine637, and phos-
phorylation of Drp1 at Serine637 leads to mitochondria
fusion, while de-phosphorylation promotes mitochon-
drial fission [35]. Western blotting analysis of subcellu-
lar fractions revealed that LPS induced translocation of
a significant amount of Drp1 to the mitochondria in a
time-dependent manner (Fig. 3d, e), suggesting a pos-
sible involvement of Drp1 in mitochondrial fission
induced by LPS, confirming observations made by
others [31]. Figure 3d and e shows the influence of
C60–COOH on LPS-induced translocation of Drp1,
which indicated that C60–COOH notably inhibited
LPS-induced translocation of Drp1. Meanwhile, BV-2
cells pretreated with C60–COOH showed increased
phosphorylation of Drp1 at Serine637 compared with
LPS-treated control cells (Fig. 4a); however, protein
levels of total Drp1 and other mitochondrial fission and
fusion factors, such as Fis1, Mfn1, Mfn2, and Opa1,
were not significantly altered either by LPS stimulation
or C60–COOH pretreatment (Fig. 4a, b). Therefore, it
was likely that the inhibitory effects of C60–COOH on
LPS-induced mitochondrial fragmentation might be
attributed to its ability to attenuate mitochondrial
localization of Drp1 promoted by modulating Ser637
de-phosphorylation. In our previous studies, we showed
that C60 derivatives such as polyhydroxylated C60 deriv-
atives regulate Nrf2 activation possibly by ROS-
mediated modification of sulfhydryl groups of Keap1
[11]. However, the molecular mechanisms of regulating
de-phosphorylation of Drp1 at Serine637 by C60–COOH
still have to be elucidated.
C60–COOH Inhibited LPS-Induced Mitochondrial ROS
Generation and Membrane Potential Collapse (ΔΨm)
Mitochondria are the primary energy producers of the cell
and play key roles in cellular signaling, apoptosis, and re-
active oxygen species (ROS) production [36]. Emerging
evidence has linked mitochondrial dysfunction such as
Fig. 3 (See legend on next page.)
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Fig. 3 a BV-2 cells were incubated with increasing doses of C60–COOH (10–100 μM) for 24 h, and the cell viability was determined by MTT assay.
The data are expressed as the mean ± SD of three independent experiments. b The effect of C60–COOH on LPS-induced mitochondrial fragmentation.
BV-2 cells transfected with DNA encoding DsRed2-mito were treated with 1 μg/mL LPS for 12 h in the presence or absence of with 50 μM C60–COOH
pretreatment for 6 h. Mitochondrial morphology was observed under a laser confocal microscope. Representative images are shown. Magnified views
(fragments) are shown in insets. c Graphs present data from the analysis of mitochondria morphology using ImageJ software. The results are for at least
20 cells per condition in each experiment. d BV-2 cells were stimulated with 1 μg/mL LPS for 6 or 12 h in the presence or absence of 50 μM C60–COOH
pretreatment for 6 h, then the cytoplasmic and mitochondrial fractions were isolated and translocation of Drp1 was analyzed by western blotting using
antibodies against Drp1. COX IV and β-actin were served as mitochondria and cytoplasmic markers, respectively. e The ratio of Drp1 expression in
mitochondria and cytoplasm were performed by densitometric analysis. The data are expressed as the mean ± SD of three independent experiments.
*p < 0.05, significantly different from LPS-treated control
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diseases, including neurodegenerative diseases and cancer
[37]. The results shown above indicate that C60–COOH
prevented LPS-induced increased mitochondrial fragmen-
tation and expression of mitochondrial fission proteins.
Excessive mitochondria fission events are normally associ-
ated with ROS generation and mitochondria dysfunction
[32]. Therefore, we determined mitochondrial ROS level
and mitochondrial membrane potential (ΔΨm) as
parameters of mitochondrial fission in BV-2 cells, which
were incubated with LPS with or without C60–COOHFig. 4 a Western blotting analysis of fission proteins (Fis1) and fusion protein
with 1 μg/mL LPS LPS for 12 h in the presence or absence of 50 μM C60–COO
proteins and fusion proteins expression in mitochondria and cytoplasm were
± SD of three independent experiments. *p < 0.05, significantly different frompretreatment by flow cytometry using MitoSOX, respect-
ively. The results showed that the pretreatment with C60–
COOH suppressed the LPS-mediated mitochondrial
ROS generation (Fig. 5a, b) and mitochondria mem-
brane depolarization (Fig. 5c, d). This may be attributed
to the antioxidant properties of C60–COOH as reported
earlier [10, 14]. Radical-scavenging abilities of C60
derivatives have been attributed to the molecular prop-
erties, including large electron affinity and formation of
electron-deficient areas on the C60, and these properties of
C60 derivatives may lead to direct ROS scavenging similars [Drp1, p-Drp1(ser637), Mfn1, Mfn2, and Opa1] in BV-2 cells stimulated
H pretreatment for 6 h was performed. b The relative levels of fission
performed by densitometric analysis. The data are expressed as the mean
LPS-treated control
Fig. 5 C60–COOH prevents loss of mitochondrial membrane potential and generation of mitochondrial reactive oxygen species (ROS) induced by
LPS. BV-2 cells were treated with 1 μg/mL of LPS for 6 h in the absence or presence of 50 μM C60–COOH pretreatment for 6 h. The cells were
then incubated either with MitoSOX Red and JC-1 fluorescent probes, respectively, and mitochondrial ROS levels and mitochondrial membrane
potential were observed under a laser confocal microscope (a and c) or analyzed by flow cytometry (b and d). Representative images are shown.
*p < 0.05, significantly different from LPS-treated control
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In addition, water-soluble C60 derivatives such as polyhy-
droxylated C60 (C60–OH) have also been reported to in-
duce phase II antioxidant enzymes, such as heme
oxygenase-1 (HO-1), γ-glutamate cysteine ligase (γ-GCS),
and NAD(P)H: quinine oxidoreductase 1 (NQO-1), to at-
tenuate oxidative stress-induced apoptosis [11]. Further
studies are needed to elucidate the molecular mechanisms
of C60–COOH to combat the deleterious action of ROS.
C60–COOH Attenuated LPS-Induced Activation of NF-κB
and MAPK Pathways
Recent studies showed that mitochondrial ROS govern-
ing the LPS-induced pro-inflammatory response in
microglia cells is associated with the activation of
mitogen-activated protein kinase (MAPK) signaling
pathways [38]. Other reports suggest that regulation of
LPS-induced mitochondrial ROS is involved in the
production of pro-inflammatory mediators in BV-2
microglia cells via NF-κB activation [39]. We, therefore,investigated the effect of C60–COOH on LPS-induced
activation of NF-κB and MAPK pathways, which have
been reported to associate with excessive mitochondria
fission induced by LPS. Western blot analysis of nu-
clear and cytoplasmic proteins showed that NF-κB p65
translocation from the cytosol to the nucleus was
increased in LPS-stimulated BV-2 cells, whereas pre-
treatment with C60–COOH inhibited NF-κB p65
nuclear localization (Fig. 6a,b). The nuclear transloca-
tion of NF-κB p65 from cytosol was confirmed by
immunolocalization of anti-NF-κB p65 antibody using
confocal microscopy (Fig. 6c). In addition, we examined
whether inhibition of mitochondria fission by C60–COOH
regulated MAPK signal pathways. Our data showed that
C60 significantly inhibited p38 MAPK, ERK1/2, and JNK
activation induced by LPS (Fig. 7a, b). This finding is simi-
lar to previous studies demonstrating that the inhibition of
increasing mitochondrial fission by Mdivi-1, a mitochon-
drial fission inhibitor, prevents LPS-induced NF-κB and
MAPK activation [32]. Our results supported the notion
Fig. 6 a Cytoplasmic and nuclear fractions from BV-2 cells treated with 1 μg/mL of LPS for 6 h with or without 50 μM C60–COOH pretreatment
for 6 h were analyzed by western blotting using antibodies against NF-κB p65. Lamin B and β-actin were used as nucleus and cytoplasmic marker,
respectively. b The ratio of NF-κB p65 in nucleus and cytoplasm was performed by densitometric analysis. The data are expressed as the mean ±
SD of three independent experiments. *p < 0.05, significantly different from LPS-treated control. c Immunolocalization of NF-κB p65 was studied
by confocal laser scanning microscopy
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mediated pathogenesis by altering MAPK kinase cascades
and activating transcription factors NF-κB in microglia
cells. Neutralization of mitochondrial ROS or suppression
of the redox pathway is thus likely to alleviate inflamma-
tion. Therefore, findings from the literature along with our
data imply a tight association and interplay betweenmitochondrial fission and ROS-mediated activation of NF-
κB and MAPK signaling pathways.
C60–COOH Suppressed LPS-Induced Pro-inflammatory
Mediators in BV-2 Cells
Microglia cells are considered the resident macrophage-
like immune cells of the brain. Although microglia provide
Fig. 7 a BV-2 cells were treated with 1 μg/mL of LPS for 1 h with or without C60–COOH (50 μM) pretreatment for 6 h, and cell lysates were
prepared and subjected to western blotting analysis for phosphorylated and total p38, ERK1/2, and JNK protein expression. b The relative
levels of phosphorylated p38, ERK1/2, and JNK expression were performed by densitometric analysis. The data are expressed as the mean ±
SD of three independent experiments. *p < 0.05, significantly different from LPS-treated control
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cellular maintenance and innate immunity, constant acti-
vation of microglia can lead to detrimental neurotoxic
effects due to excessive production of cytotoxic mediators
such as nitric oxide (NO), prostaglandin E2 (PGE2), and
other pro-inflammatory cytokines [27]. Moreover, previ-
ous studies demonstrate that mitochondria fission in acti-
vated microglia cells may be necessary for the expression
of pro-inflammatory mediators [32]. Previous studies sug-
gested that C60 derivatives could penetrate cell membrane,
gain access to intracellular compartments, and interact
with proteins, resulting in regulation of a series of signal-
ing pathways [11, 16]. In this study, we observed that
treatment with C60–COOH for 6 or 12 h led to a signifi-
cant regulation of fission/fusion protein. The time-period
of incubation was consistent with our previous observa-
tion [11], showing that pretreatment with C60 derivatives
for up to 6 h induced Nrf2-regulated anti-inflammatory
proteins such as HO-1. In this study, BV-2 cells were stim-
ulated with LPS in the presence or absence of C60–COOH
pretreatment for 6 h, and then the levels of various pro-
inflammatory mediators were determined. As expected,our data showed that pretreatment with C60–COOH
decreased LPS-induced up-regulated expression of pro-
inflammatory protein, such as inducible nitric oxide
synthase (iNOS) and cyclooxygenase-2 (Cox-2) (Fig. 8a–c).
As shown in Fig. 8d, we also observed that C60–COOH
had similar inhibitory effects on LPS-induced other
pro-inflammatory mediators, such as TNF-α, IL-1β, and
IL-6. These results further supported a critical role of
excessive mitochondrial fission in the induction of pro-
inflammatory mediators in microglia cells as described
previously [32]. Therefore, it is possible that modulation
of mitochondrial dynamics may be a useful therapeutic
modality for preventing neurodegenerative disorders be-
cause microglia-mediated neuroinflammation is associated
with neurodegenerative processes.
Conclusions
Mitochondrial dysfunction is associated with neuropa-
thies, and mitochondrial dynamics are altered in neuro-
degenerative diseases. Thus, modulation of mitochondria
dynamics should lead to the development of new thera-
peutic strategies for treating mitochondria-associated
Fig. 8 a COX-2 and iNOS expression were analyzed by western blotting analysis in BV-2 cells treated with 1 μg/mL of LPS for 12 h in the absence
or presence of pretreatment with 50 μM C60–COOH for 6 h. b, c The relative levels of COX-2 and iNOS expression were performed by densitometric
analysis. The data are expressed as the mean ± SD of three independent experiments. *p < 0.05, significantly different from LPS-treated control. b,
d BV-2 cells were pretreated with 50 μM C60–COOH for 6 h and then stimulated with 1 μg/mL LPS for 12 h. The amount of PGE2, NO, TNF-α,
IL-β, and IL-6 released into media were measured as described in the “Methods” section. The data are expressed as the mean ± SD of three
independent experiments. *p < 0.05, significantly different from LPS-treated control
Ye et al. Nanoscale Research Letters  (2015) 10:246 Page 11 of 12diseases such as neurodegenerative diseases. In this
study, we identified carboxylic acid C60 derivatives as a
potent regulator of mitochondria dynamics. Although
mitochondria can be considered a cellular target for
C60–COOH, the precise mechanism of their effect on
mitochondria has not been fully elucidated. Here, we first
investigated the effect of C60–COOH on mitochondria dy-
namics, showing that C60–COOH treatment prevents
mitochondria fragmentation, depolarization of mitochon-
dria membrane potential, as well as attenuation of NF-κBand MAPK activation, thus leading to reduced neuroin-
flammatory response.
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